Nordic AML Meeting 11-12 September 2025
Save the dates for the upcoming Nordic AML Meeting in Bergen, Norway, 2025.
12 events found.
Events
-
-
-
-
Personalized Medicine in the Treatment of AML
Jazz Pharmaceuticals is pleased to invite hematologists from the Nordic AML Group to join a distinguished academic webinar featuring Prof. Dr. med. Lars Bullinger and Prof. Bjørn Tore Gjertsen, two leading experts in hematology and leukemia research. Find more info using this link. Register using this QR code
-
-
NAMLG – Steering group meeting
Virtual EventAgenda and meeting link will be sent via e-mail.
-
Best of ASH 2025 by Lund
At Best of ASH 2025, hematologists in Lund, Sweden present their top picks from the annual meeting of the American Society of Hematology (ASH) cutting through the volume to focus on data that change how we treat patients. Expect concise, expert-led updates on key trials, late-breaking abstracts, and their real-world implications across hematology. Live on […]
-
-
Webinar – Innovations in AML care: Integrating Novel Treatments into Nordic Practice
Virtual EventThe Nordic AML Group’s Educational Working Group invites you to a scientific webinar focusing on recent innovations in the treatment of AML and their implementation in Nordic clinical practice. The webinar will feature three expert speakers covering: - The evolving AML treatment landscape by professor Gail Roboz (New York) - Early Nordic experience with new […]
-
-
NAMLG – Steering group meeting
Agenda and meeting link will be sent via e-mail.
-
Germline Predisposition to Myeloid Neoplasms – Case discussions
Join the MDR for patients with germline predisposition for hematological malignancies. This meeting is for clinicians within the Nordics via this Zoom-link. If you want to discuss a case, please send 1-2 summary slides with the most important information to Panagiotis Baliakas (panagiotis.baliakas@igp.uu.se), Uppsala, Sweden.
-
Webinar – Ask the expert: FLT3 MRD testing in AML patients
Take the chance to join an Astellas Pharma sponsored webinar with Dr. Mark J. Levis, MD, PhD, Baltimore, USA, entitled Ask the expert: FLT3 MRD testing in AML patients via Teams with the following agenda: Assess the current minimal residual disease testing modalities/methods Evaluate appropriate timing and efficacy of different FLT3 MRD testing modalities […]
-
-
Germline Predisposition to Myeloid Neoplasms – Case discussions
Join the MDR for patients with germline predisposition for hematological malignancies. This meeting is for clinicians within the Nordics.via this Zoom-link. If you want to discuss a case, please send 1-2 summary slides with the most important information to Panagiotis Baliakas (panagiotis.baliakas@igp.uu.se), Uppsala, Sweden.
-
-
NAMLG meeting @ EHA2026
EHA Meeting Hub, rooms K18 + K19Agenda - 2026-06-13 - NAMLG meeting Welcome to our meeting @ EHA June 13 @ 12:30 - 14:00 at EHA Meeting Hub, rooms K18 + K19. Agenda 1. Approval of Minutes from Last Meeting 2. Planning 2027 NAMLG Election 3. Nordic AML Meeting 2026 in Bergen - Update and Promotion 4. LD VenEx Trial - […]
-
-
-